Beit Jala Pharmaceutical Company Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2018
Beit Jala Pharmaceutical Company announced unaudited earnings results for the first quarter ended March 31, 2018. For the year, the company reported sales of JOD 1,524,137 against JOD 1,637,281 a year ago. Net income before tax was JOD 89,296 against JOD 96,161 a year ago. Net income after tax was JOD 82,599 against JOD 88,949 a year ago. Basic and diluted earnings per share were JOD 0.012 against JOD 0.013 a year ago. Net cash flow from operating activities was JOD 651,441 against JOD 225,884 a year ago. Purchase of property, plant and equipment was JOD 415,638 against JOD 559,248 a year ago.